Clinical trials
Hypercholesterolemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Unknown status | 9 |
| Active, not recruiting | 7 |
| Recruiting | 7 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 15 |
| University of Bologna | 11 |
| Federico II University | 6 |
| Regeneron Pharmaceuticals | 4 |
| Sanofi | 4 |
| Kowa Research Europe | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| Centro Cardiologico Monzino | 2 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 81 |
| Dyslipidemias | 11 |
| Hyperlipidemias | 8 |
| Hyperlipoproteinemia Type II | 7 |
| Cardiovascular Diseases | 6 |
| Atherosclerosis | 5 |
| Homozygous Familial Hypercholesterolemia | 5 |
| Diabetes Mellitus | 4 |
| Hypertension | 4 |
| Obesity | 4 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.